Regents of the University of California on behalf of UCLA Fertility and Reproductive Health Center – FDA 483, Jan 11, 2023
The FDA inspected Regents of the University of California on behalf of UCLA Fertility and Reproductive Health Center in Los Angeles, CA, and identified significant deficiencies in their donor screening and eligibility determination processes. The facility failed to adequately screen oocyte and semen donors for Zika virus and did not establish proper procedures for donor eligibility. Additionally, donors were deemed eligible prior to the review of all relevant communicable disease testing records.
- Company
- Regents of the University of California on behalf of UCLA Fertility and Reproductive Health Center
- Inspection date
- January 11, 2023
- Product type
- biologics
ID · 5206a5e8-80e1-4239-b594-b9623ca7bd8d
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.